BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31407859)

  • 1. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
    Labayru G; Aliri J; Zulaica M; López de Munain A; Sistiaga A
    J Neuropsychol; 2020 Mar; 14(1):121-134. PubMed ID: 31407859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
    Gallais B; Gagnon C; Mathieu J; Richer L
    Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
    Winblad S; Samuelsson L; Lindberg C; Meola G
    Eur J Neurol; 2016 Sep; 23(9):1471-6. PubMed ID: 27323306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
    Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
    Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.
    Modoni A; Silvestri G; Vita MG; Quaranta D; Tonali PA; Marra C
    J Neurol; 2008 Nov; 255(11):1737-42. PubMed ID: 18821050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1.
    Sistiaga A; Urreta I; Jodar M; Cobo AM; Emparanza J; Otaegui D; Poza JJ; Merino JJ; Imaz H; Martí-Massó JF; López de Munain A
    Psychol Med; 2010 Mar; 40(3):487-95. PubMed ID: 19627641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study.
    Fujino H; Suwazono S; Ueda Y; Kobayashi M; Nakayama T; Imura O; Matsumura T; Takahashi MP
    J Neuromuscul Dis; 2023; 10(6):1083-1092. PubMed ID: 37599536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1.
    Ricci FS; Vacchetti M; Brusa C; D'Alessandro R; La Rosa P; Martone G; Davico C; Vitiello B; Mongini TE
    Eur J Paediatr Neurol; 2022 Jul; 39():59-64. PubMed ID: 35679764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I.
    Lopez-Titla MM; Chirino A; Cruz Solis SV; Hernandez-Castillo CR; Diaz R; Márquez-Quiroz LDC; Magaña JJ; Beltrán-Parrazal L; Fernandez-Ruiz J
    J Neuroimaging; 2021 Jan; 31(1):192-198. PubMed ID: 32936994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.
    Baldanzi S; Cecchi P; Fabbri S; Pesaresi I; Simoncini C; Angelini C; Bonuccelli U; Cosottini M; Siciliano G
    Neuroimage Clin; 2016; 12():190-7. PubMed ID: 27437180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and adaptive functioning in congenital and childhood forms of myotonic dystrophy type 1: a longitudinal study.
    Lindeblad G; Kroksmark AK; Ekström AB
    Dev Med Child Neurol; 2019 Oct; 61(10):1214-1220. PubMed ID: 30706460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis.
    Okkersen K; Buskes M; Groenewoud J; Kessels RPC; Knoop H; van Engelen B; Raaphorst J
    Cortex; 2017 Oct; 95():143-155. PubMed ID: 28892766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the pattern of cognitive impairments between juvenile and adult onset myotonic dystrophy type 1.
    Woo J; Lee HW; Park JS
    J Clin Neurosci; 2019 Oct; 68():92-96. PubMed ID: 31371188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural white matter networks in myotonic dystrophy type 1.
    van Dorst M; Okkersen K; Kessels RPC; Meijer FJA; Monckton DG; van Engelen BGM; Tuladhar AM; Raaphorst J;
    Neuroimage Clin; 2019; 21():101615. PubMed ID: 30522973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.
    Cabada T; Díaz J; Iridoy M; López P; Jericó I; Lecumberri P; Remirez B; Seijas R; Gomez M
    Neuroradiology; 2021 Jul; 63(7):1019-1029. PubMed ID: 33237431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow-up study.
    Garmendia J; Labayru G; Zulaica M; Villanúa J; López de Munain A; Sistiaga A
    Eur J Neurol; 2023 Jan; 30(1):215-223. PubMed ID: 36256504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-year follow-up study of an atypical case of myotonic dystrophy.
    Macniven JA; Graham NL; Davies RR; Wilson BA
    Brain Inj; 2005 Dec; 19(14):1213-21. PubMed ID: 16286337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
    Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
    Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychological profile in patients with myotonic dystrophy type 1: a four-year follow-up study].
    Díaz-Leiva J; Cabada-Giadás T; Seijas-Gómez R; Jericó-Pascual I; López-Sala P; Iridoy-Zulet M
    Rev Neurol; 2020 Jun; 70(11):406-412. PubMed ID: 32436207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.
    Peric S; Rakocevic Stojanovic V; Mandic Stojmenovic G; Ilic V; Kovacevic M; Parojcic A; Pesovic J; Mijajlovic M; Savic-Pavicevic D; Meola G
    Neurol Sci; 2017 Mar; 38(3):415-423. PubMed ID: 27896491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.